Our results indicate that breast cancer patients have significantly lower expression levels of GPD1 compared with normal controls, which was further verified in 63 paired human breast cancer tissues (54 out of 63) compared with the adjacent normal tissues. This evidence concerns the gene GPD1 and breast cancer.